Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

24.11 -0.11 (-0.45%)
Streaming Delayed Price Updated: 10:51 AM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 191,648
Open 24.28
Bid (Size) 24.10 (2)
Ask (Size) 24.12 (3)
Prev. Close 24.22
Today's Range 24.06 - 24.28
52wk Range 22.01 - 33.71
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Where Alkermes Stands With Analysts
Via Benzinga
Why Is Mural Oncology (MURA) Stock Up 59% Today?
Mural Oncology stock is climbing higher on Friday as the company's shares bounce back from a dip yesterday during its public debut. 
Via InvestorPlace

Performance

YTD
-6.80%
-6.80%
1 Month
-0.82%
-0.82%
3 Month
-11.43%
-11.43%
6 Month
-17.37%
-17.37%
1 Year
+0.58%
+0.58%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
NASDAQ:ALKS: good value for what you're paying.
Via Chartmill
3 Growth Stocks Set to Dominate the Decade
Via InvestorPlace
NASDAQ:ALKS—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via Chartmill
Why Alkermes Stock Is Sinking Today
Via The Motley Fool
Why NASDAQ:ALKS Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
Via InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering.
Via Chartmill
NASDAQ:ALKS, an undervalued stock with good fundamentals.
Via Chartmill
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
Via Benzinga
Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.
Via Investor's Business Daily
Alkermes Honors Women's Equality Day
Via ACCESSWIRE
Earnings Preview: Alkermes
Via Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
While growth is established for NASDAQ:ALKS, the stock's valuation remains reasonable.
Via Chartmill
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Via Benzinga
NASDAQ:ALKS is showing good growth, while it is not too expensive.
Via Chartmill
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Top Biotech Stocks Defying the Bear Market
Via The Motley Fool
Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega
Via Benzinga
Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor
From Sarissa Capital Management LP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.